You should not take them if any of the following apply: Medical conditions Personal or family history of medullary thyroid carcinoma (a type of thyroid cancer) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) History of pancreatitis Severe kidney or liver disease Diabetic retinopathy Severe gastrointestinal disease, including gastroparesis Allergy to semaglutide or any ingredient in the tablet Pregnancy and breastfeeding Pregnant, planning pregnancy, or breastfeeding Other medications Currently taking other GLP-1 medicines (Wegovy injections, Ozempic, Rybelsus) Taking insulin or certain diabetes medications (dose adjustments may be required under medical supervision) Age Under 18 years of age If you're unsure whether Wegovy tablets are suitable for you, our prescribers can assess your circumstances through a short online consultation
Protein consumption should be between 60 and 75 g/day, but dont go overboard on the protein
FDA bans compounded weight loss drugs this month This month, the window open to an era when compounded versions of glucagon-like peptide 1 (GLP-1) weight loss medications became available is expected to close
Whether you need a quick energy boost, a detox session, or a beauty-enhancing treatment, our team delivers professional care right to your doorstep
This pattern mirrors what we see with other weight loss medications and may relate to differences in baseline body composition